BridgeMD
New treatment option for Breast Cancer Invasive
Official title Confocal Histolog Scanner in Routine Breast-Conserving Surgery (CHiB)
ClinicalTrials.gov ID: NCT06958991
What this study is testing
- What it's testing
- The clinical performance study is collecting data from the use of a CE mark product used within the scope of its intended purpose to intraoperatively visualize tissue specimen. The subjects are not submitted to invasive and burdensome procedures compared to the standard of care surgical practices and regular use of the CE mark product.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Adult female Subject ≥18 years old.
- Subject scheduled for breast conserving surgery of invasive and/or in-situ ductal and lobular carcinoma.
- Subject is able to read, understand and sign the informed consent.
You likely can't join if
- Subject with planned mastectomy
- Subject does not speak French- Subject with planned tumor-adapted breast reduction
- Subject is pregnant/ lactating. people pregnant/lactating are excluded because such people are presenting additional risks during the surgery and...
- Participation in any other clinical study that would affect data acquisition.
The study team makes the final eligibility decision.
Where it's taking place
- Villars-sûr-glâne, Canton of Fribourg, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Villars-sûr-glâne, Canton of Fribourg, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.